Tim Kutzkey is a Managing Partner at The Column Group, based in San Francisco, California, United States. He invests in Biotechnology, Life Sciences, Therapeutics, Drug Development, Pharmaceuticals, and Neuroscience, primarily in the United States, across Seed, Series A–D, Venture Round, Private Equity, Post-IPO Equity, and public-stage opportunities. He is operating off an $824 million fund raised in April 2020. He has invested in companies like Surrozen, Nura Bio, Synthekine, Cajal Neuroscience, and Nurix Therapeutics. Before The Column Group, he was a Scientist at KAI Pharmaceuticals and a Post-doc at UC Berkeley. Tim holds a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley, and also attended Stanford University.
Tim Kutzkey, Managing Partner @ The Column. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Tim Kutzkey from The Column Group. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Tim
Map your path to Tim instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Tim
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.